Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects. Pilmeyer, J., Huijbers, W., Lamerichs, R., Jansen, J. F. A., Breeuwer, M., & Zinger, S. J Neuroimaging, 2022. Pilmeyer, Jesper Huijbers, Willem Lamerichs, Rolf Jansen, Jacobus F A Breeuwer, Marcel Zinger, Svitlana eng Review J Neuroimaging. 2022 May 21. doi: 10.1111/jon.13011.![Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Objective diagnosis and prognosis in major depressive disorder (MDD) remains a challenge due to the absence of biomarkers based on physiological parameters or medical tests. Numerous studies have been conducted to identify functional magnetic resonance imaging-based biomarkers of depression that either objectively differentiate patients with depression from healthy subjects, predict personalized treatment outcome, or characterize biological subtypes of depression. While there are some findings of consistent functional biomarkers, there is still lack of robust data acquisition and analysis methodology. According to current findings, primarily, the anterior cingulate cortex, prefrontal cortex, and default mode network play a crucial role in MDD. Yet, there are also less consistent results and the involvement of other regions or networks remains ambiguous. We further discuss image acquisition, processing, and analysis limitations that might underlie these inconsistencies. Finally, the current review aims to address and discuss possible remedies and future opportunities that could improve the search for consistent functional imaging biomarkers of depression. Novel acquisition techniques, such as multiband and multiecho imaging, and neural network-based cleaning approaches can enhance the signal quality in limbic and frontal regions. More comprehensive analyses, such as directed or dynamic functional features or the identification of biological depression subtypes, can improve objective diagnosis or treatment outcome prediction and mitigate the heterogeneity of MDD. Overall, these improvements in functional MRI imaging techniques, processing, and analysis could advance the search for biomarkers and ultimately aid patients with MDD and their treatment course.
@article{RN302,
author = {Pilmeyer, J. and Huijbers, W. and Lamerichs, R. and Jansen, J. F. A. and Breeuwer, M. and Zinger, S.},
title = {Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects},
journal = {J Neuroimaging},
note = {Pilmeyer, Jesper
Huijbers, Willem
Lamerichs, Rolf
Jansen, Jacobus F A
Breeuwer, Marcel
Zinger, Svitlana
eng
Review
J Neuroimaging. 2022 May 21. doi: 10.1111/jon.13011.},
abstract = {Objective diagnosis and prognosis in major depressive disorder (MDD) remains a challenge due to the absence of biomarkers based on physiological parameters or medical tests. Numerous studies have been conducted to identify functional magnetic resonance imaging-based biomarkers of depression that either objectively differentiate patients with depression from healthy subjects, predict personalized treatment outcome, or characterize biological subtypes of depression. While there are some findings of consistent functional biomarkers, there is still lack of robust data acquisition and analysis methodology. According to current findings, primarily, the anterior cingulate cortex, prefrontal cortex, and default mode network play a crucial role in MDD. Yet, there are also less consistent results and the involvement of other regions or networks remains ambiguous. We further discuss image acquisition, processing, and analysis limitations that might underlie these inconsistencies. Finally, the current review aims to address and discuss possible remedies and future opportunities that could improve the search for consistent functional imaging biomarkers of depression. Novel acquisition techniques, such as multiband and multiecho imaging, and neural network-based cleaning approaches can enhance the signal quality in limbic and frontal regions. More comprehensive analyses, such as directed or dynamic functional features or the identification of biological depression subtypes, can improve objective diagnosis or treatment outcome prediction and mitigate the heterogeneity of MDD. Overall, these improvements in functional MRI imaging techniques, processing, and analysis could advance the search for biomarkers and ultimately aid patients with MDD and their treatment course.},
keywords = {Mri
biomarkers
major depressive disorder
review},
ISSN = {1552-6569 (Electronic)
1051-2284 (Linking)},
DOI = {10.1111/jon.13011},
url = {https://www.ncbi.nlm.nih.gov/pubmed/35598083},
year = {2022},
type = {Journal Article}
}
Downloads: 0
{"_id":"iPNM23sy7NPS3JN8p","bibbaseid":"pilmeyer-huijbers-lamerichs-jansen-breeuwer-zinger-functionalmriinmajordepressivedisorderareviewoffindingslimitationsandfutureprospects-2022","author_short":["Pilmeyer, J.","Huijbers, W.","Lamerichs, R.","Jansen, J. F. A.","Breeuwer, M.","Zinger, S."],"bibdata":{"bibtype":"article","type":"Journal Article","author":[{"propositions":[],"lastnames":["Pilmeyer"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Huijbers"],"firstnames":["W."],"suffixes":[]},{"propositions":[],"lastnames":["Lamerichs"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Jansen"],"firstnames":["J.","F.","A."],"suffixes":[]},{"propositions":[],"lastnames":["Breeuwer"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Zinger"],"firstnames":["S."],"suffixes":[]}],"title":"Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects","journal":"J Neuroimaging","note":"Pilmeyer, Jesper Huijbers, Willem Lamerichs, Rolf Jansen, Jacobus F A Breeuwer, Marcel Zinger, Svitlana eng Review J Neuroimaging. 2022 May 21. doi: 10.1111/jon.13011.","abstract":"Objective diagnosis and prognosis in major depressive disorder (MDD) remains a challenge due to the absence of biomarkers based on physiological parameters or medical tests. Numerous studies have been conducted to identify functional magnetic resonance imaging-based biomarkers of depression that either objectively differentiate patients with depression from healthy subjects, predict personalized treatment outcome, or characterize biological subtypes of depression. While there are some findings of consistent functional biomarkers, there is still lack of robust data acquisition and analysis methodology. According to current findings, primarily, the anterior cingulate cortex, prefrontal cortex, and default mode network play a crucial role in MDD. Yet, there are also less consistent results and the involvement of other regions or networks remains ambiguous. We further discuss image acquisition, processing, and analysis limitations that might underlie these inconsistencies. Finally, the current review aims to address and discuss possible remedies and future opportunities that could improve the search for consistent functional imaging biomarkers of depression. Novel acquisition techniques, such as multiband and multiecho imaging, and neural network-based cleaning approaches can enhance the signal quality in limbic and frontal regions. More comprehensive analyses, such as directed or dynamic functional features or the identification of biological depression subtypes, can improve objective diagnosis or treatment outcome prediction and mitigate the heterogeneity of MDD. Overall, these improvements in functional MRI imaging techniques, processing, and analysis could advance the search for biomarkers and ultimately aid patients with MDD and their treatment course.","keywords":"Mri biomarkers major depressive disorder review","issn":"1552-6569 (Electronic) 1051-2284 (Linking)","doi":"10.1111/jon.13011","url":"https://www.ncbi.nlm.nih.gov/pubmed/35598083","year":"2022","bibtex":"@article{RN302,\n author = {Pilmeyer, J. and Huijbers, W. and Lamerichs, R. and Jansen, J. F. A. and Breeuwer, M. and Zinger, S.},\n title = {Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects},\n journal = {J Neuroimaging},\n note = {Pilmeyer, Jesper\nHuijbers, Willem\nLamerichs, Rolf\nJansen, Jacobus F A\nBreeuwer, Marcel\nZinger, Svitlana\neng\nReview\nJ Neuroimaging. 2022 May 21. doi: 10.1111/jon.13011.},\n abstract = {Objective diagnosis and prognosis in major depressive disorder (MDD) remains a challenge due to the absence of biomarkers based on physiological parameters or medical tests. Numerous studies have been conducted to identify functional magnetic resonance imaging-based biomarkers of depression that either objectively differentiate patients with depression from healthy subjects, predict personalized treatment outcome, or characterize biological subtypes of depression. While there are some findings of consistent functional biomarkers, there is still lack of robust data acquisition and analysis methodology. According to current findings, primarily, the anterior cingulate cortex, prefrontal cortex, and default mode network play a crucial role in MDD. Yet, there are also less consistent results and the involvement of other regions or networks remains ambiguous. We further discuss image acquisition, processing, and analysis limitations that might underlie these inconsistencies. Finally, the current review aims to address and discuss possible remedies and future opportunities that could improve the search for consistent functional imaging biomarkers of depression. Novel acquisition techniques, such as multiband and multiecho imaging, and neural network-based cleaning approaches can enhance the signal quality in limbic and frontal regions. More comprehensive analyses, such as directed or dynamic functional features or the identification of biological depression subtypes, can improve objective diagnosis or treatment outcome prediction and mitigate the heterogeneity of MDD. Overall, these improvements in functional MRI imaging techniques, processing, and analysis could advance the search for biomarkers and ultimately aid patients with MDD and their treatment course.},\n keywords = {Mri\nbiomarkers\nmajor depressive disorder\nreview},\n ISSN = {1552-6569 (Electronic)\n1051-2284 (Linking)},\n DOI = {10.1111/jon.13011},\n url = {https://www.ncbi.nlm.nih.gov/pubmed/35598083},\n year = {2022},\n type = {Journal Article}\n}\n\n","author_short":["Pilmeyer, J.","Huijbers, W.","Lamerichs, R.","Jansen, J. F. A.","Breeuwer, M.","Zinger, S."],"key":"RN302","id":"RN302","bibbaseid":"pilmeyer-huijbers-lamerichs-jansen-breeuwer-zinger-functionalmriinmajordepressivedisorderareviewoffindingslimitationsandfutureprospects-2022","role":"author","urls":{"Paper":"https://www.ncbi.nlm.nih.gov/pubmed/35598083"},"keyword":["Mri biomarkers major depressive disorder review"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://raw.githubusercontent.com/jansenjfa1/bibbase.github.io/master/jansenjfa.bib","dataSources":["TCkfRWJAZvbLAZi29"],"keywords":["mri biomarkers major depressive disorder review"],"search_terms":["functional","mri","major","depressive","disorder","review","findings","limitations","future","prospects","pilmeyer","huijbers","lamerichs","jansen","breeuwer","zinger"],"title":"Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects","year":2022}